Stocks · Health care · Biological Products, (No Diagnostic Substances)

Gilead Sciences

GILD Clue Score57

United States Fiscal year ends December CIK 0000882095 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

18 insiders · 83 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daniel Patrick O'Day

Chairman & CEO

—

$56.58M (32) scheduled

−$56.58M

551,683

0.0445%

$94.37M

+11.2%

Johanna Mercier

Chief Comm & Corp Aff Officer

—

$18.64M (23) scheduled

−$18.64M

113,684

0.0092%

$19.45M

+45.5%

Deborah H Telman

EVP, Corporate Affairs & GC

—

$6.59M (3) scheduled

−$6.59M

43,676

0.0035%

$7.47M

+104.9%

Andrew D Dickinson

Chief Financial Officer

—

$4.85M (12) scheduled

−$4.85M

161,096

0.0130%

$27.56M

+15.5%

Anthony Welters

Director

—

$2.68M (4) scheduled

−$2.68M

12,894

0.0010%

$2.21M

+26.0%

Jeffrey Bluestone

Director

—

$1.97M (7) scheduled

−$1.97M

10,066

0.0008%

$1.72M

+76.3%

Kelly A. Kramer

Director

—

$713.19K (2) scheduled

−$713.19K

1,339

0.0001%

$229.05K

0.0%

Merdad Parsey

Chief Medical Officer

—

—

—

82,850

0.0067%

$14.17M

−17.3%

Diane E. Wilfong

Interim Corp Controller & CAO

—

—

—

46,259

0.0037%

$7.91M

+2.6%

Sandra Patterson

SVP, Controllership

—

—

—

39,453

0.0032%

$6.75M

+6.9%

Jacqueline K Barton

Director

—

—

—

27,202

0.0022%

$4.65M

+10.8%

Dietmar Berger

Chief Medical Officer

—

—

—

19,522

0.0016%

$3.34M

—

Harish Manwani

Director

—

—

—

15,015

0.0012%

$2.57M

+16.6%

Javier Rodriguez

Director

—

—

—

13,364

0.0011%

$2.29M

+24.9%

Wettan Keeley M Cain

EVP Gen Counsel, Legal & Comp

—

—

—

8,759

0.0007%

$1.50M

+122.1%

Sandra Horning

Director

—

—

—

6,293

0.0005%

$1.08M

+73.3%

Ted W Love

Director

—

—

—

5,484

0.0004%

$938.11K

+94.3%

Erin Burkhart

SVP, Controllership

—

—

—

1,455

0.0001%

$248.90K

—